このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

The Effect of a Structured Workplace Exercise Program on 360-Degree Performance Evaluation, Job Motivation, Productivity, and Quality of Work Life (PADRA-EXER)

2026年9月11日 更新者:Zinat Ebrahimi、Islamic Azad University, Sanandaj

The Effect of a 12-Week Structured Workplace Exercise Program on AGIO Productivity, 360-Degree Performance Evaluation, Herzberg Job Motivation, and Walton Quality of Work Life: A Quasi-Experimental Pre-Test/Post-Test Study in a Medical Garment Manufacturing Factory

This quasi-experimental, single-group pre-test/post-test study is designed to evaluate the effects of a 12-week structured workplace exercise program on four human capital indicators among employees of a medical garment manufacturing factory in Sanandaj, Kurdistan Province, Iran. The study population consists of 150 employees working in production, cutting, quality control, technical maintenance, and administrative departments. Following clinical screening by an occupational medicine specialist and completion of the PAR-Q questionnaire, eligible participants will be enrolled. The exercise intervention consists of 24 sessions (2 sessions per week, 60 minutes each) delivered by a certified fitness instructor. Outcome measures include AGIO human resource productivity, 360-degree performance evaluation, Herzberg job motivation, and Walton quality of work life, assessed at baseline and post-intervention. This study has been approved by the Research Ethics Committee of Islamic Azad University, Sanandaj Branch (IR.IAU.SANANDAJ.REC.1405.152).

調査の概要

詳細な説明

This study employs a quasi-experimental, single-group pre-test/post-test design with a mixed-methods (quantitative-qualitative) approach. The study is conducted at a medical protective apparel and healthcare sanitary wear manufacturing plant in Sanandaj, Kurdistan Province, Iran. Workers primarily perform sedentary-to-light manual tasks including fabric cutting, sewing, quality inspection, and packaging under a two-shift rotation system. The study period runs from April to July 2025 (1 Ordibehesht to 24 Tir 1404, Iranian calendar). Baseline (T1) assessments are completed one week before session 1; post-intervention (T2) assessments are completed within one week of session 24. The study protocol was approved by the Research Ethics Committee of Islamic Azad University, Sanandaj Branch (Ethics Code: IR.IAU.SANANDAJ.REC.1405.152). Written informed consent is obtained from all participants before enrolment.

Participants: All 150 employees of the facility are invited for eligibility screening. A licensed occupational medicine physician conducts clinical examinations supplemented by the Physical Activity Readiness Questionnaire (PAR-Q). Employees with uncontrolled cardiovascular disease, severe respiratory disorders, musculoskeletal conditions incompatible with moderate-intensity exercise, pregnancy, or other physician-identified contraindications are excluded. Eligible employees who provide written informed consent are enrolled. Sample size adequacy is confirmed using Cochran's formula for finite populations (N = 150; 95% CI; margin of error = 0.05; p = q = 0.50), and statistical power is verified using G*Power 3.1.

Intervention Protocol: The 12-week structured exercise program comprises 24 sessions (2 × 60 min/week), delivered by a fitness instructor holding a Grade-2 certification from the Physical Fitness Federation of the Islamic Republic of Iran. Sessions are consistently held at 10:00 AM before shift handovers. The facility's dedicated sports hall provides a climate-controlled environment (25-26°C; 60% relative humidity) consistent with ACSM guidelines for moderate-intensity aerobic exercise. Each session includes a 10-minute warm-up with joint mobility and dynamic stretching, a 40-minute main phase combining intermittent aerobic exercise (60-75% of heart rate reserve) with functional core exercises, calisthenics, and cooperative small-sided games, and a 10-minute cool-down with static stretching, spinal elongation, and guided diaphragmatic breathing. Aerobic intensity is targeted at 60-75% of heart rate reserve using the Karvonen formula, monitored via the Borg Rating of Perceived Exertion (RPE; 6-20 scale; target 12-14). All phases are instructor-led; no self-directed activities are included.

Outcome Measures: Four validated instruments are administered at baseline (T1) and post-intervention (T2). (1) The 40-item Herzberg Dual-Factor Motivation Questionnaire (Darchini, 2015) assesses two independent subscales: Intrinsic/Motivator factors (20 items) and Extrinsic/Hygiene factors (20 items), using a 5-point Likert scale. (2) The 26-item AGIO Human Resource Productivity Scale (Hersey and Blanchard, 1980; validated by Mehri, 2013) assesses seven subscales: Ability, Role Clarity, Organizational Support, Motivation, Feedback, Credibility, and Environmental Fit, using a 5-point Likert scale. (3) A 360-degree performance evaluation questionnaire (Poursoltani et al., 2010) collects ratings from four sources: supervisor, peer, subordinate, and self. (4) The Walton Quality of Work Life Questionnaire (Walton, 1973; Iranian validation by Rahimi, 2005) assesses eight dimensions including fair compensation, safe working conditions, and growth opportunities.

Statistical Analysis Plan: All analyses will use IBM SPSS Statistics v26.0. Composite scale scores (≥ 10 items) will be treated as continuous interval-level data for parametric analyses. Shapiro-Wilk tests will verify univariate normality. For the primary pre-post comparisons, paired-samples t-tests will be used with a Bonferroni-adjusted significance threshold. For the cross-sectional association between post-intervention motivation, 360-degree appraisal, and productivity, an enter-method multiple linear regression will be used. A supplementary regression will include T1 motivation as a covariate. Model assumptions will be verified (VIF < 2.0 for multicollinearity; Durbin-Watson for autocorrelation). One-way ANOVA with partial eta-squared will examine whether demographic characteristics moderate post-intervention outcomes. Qualitative interview data from 10 semi-structured interviews will undergo thematic content analysis (open, axial, and selective coding) as a planned exploratory component of the study.

研究の種類

介入

入学 (実際)

109

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Kurdistan Province
      • Sanandaj、Kurdistan Province、イラン、6616947455
        • PADRA Medical Garment Manufacturing Factory

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人

健康ボランティアの受け入れ

はい

説明

Inclusion Criteria:

  1. Employment at PADRA Medical Garment Manufacturing Factory
  2. Age between 20 and 60 years
  3. Successful completion of clinical examination by an occupational medicine specialist
  4. Successful completion of the PAR-Q (Physical Activity Readiness Questionnaire) with no contraindications
  5. Voluntary written informed consent to participate in the study
  6. Willingness to attend 2 exercise sessions per week for 12 weeks

Exclusion Criteria:

  1. Uncontrolled cardiovascular diseases (e.g., uncontrolled hypertension, recent myocardial infarction)
  2. Severe respiratory disorders (e.g., severe asthma, COPD)
  3. Musculoskeletal problems that contraindicate moderate-intensity physical activity
  4. Any medical contraindication for moderate-intensity exercise as determined by occupational medicine specialist
  5. Pregnancy
  6. Withdrawal of informed consent at any stage of the study
  7. Failure to complete pre-test or post-test questionnaires

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:他の
  • 割り当て:なし
  • 介入モデル:単一グループの割り当て
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Workplace Exercise Intervention Group
Participants received a 12-week structured workplace exercise program consisting of 24 sessions (60 minutes each, 2 sessions per week). Each session included a 10-minute warm-up with dynamic movements and joint mobilization, a 40-minute main phase combining intermittent aerobic exercise (60-75% of heart rate reserve) with functional endurance training and team-based games (volleyball, small-sided football, passing drills), and a 10-minute cool-down with static stretching, relaxation, and guided diaphragmatic breathing. Exercise intensity was monitored using the Borg Rating of Perceived Exertion (RPE) scale with a target range of 12-14. The intervention was conducted at the factory's adjacent sports hall at 10:00 AM, with ambient temperature maintained at 25-26°C. Attendance was high: 107 out of 109 participants completed ≥22 of 24 sessions. No adverse events or protocol deviations were recorded. Outcomes measured pre- and post-intervention included AGIO productivity, 360-degree perfor
A 12-week structured exercise program consisting of 24 sessions (60 minutes each, 2 sessions per week). Each session includes a 10-minute warm-up with dynamic movements and joint mobilization, a 40-minute main phase combining intermittent aerobic exercise (60-75% of heart rate reserve) with functional endurance training and team-based games (volleyball, small-sided football, passing drills), and a 10-minute cool-down with static stretching, relaxation, and guided diaphragmatic breathing. Intensity monitored by Borg RPE scale (target 12-14). Conducted at factory sports hall, 10:00 AM, 25-26°C. No adverse events recorded.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
AGIO Productivity Score
時間枠:Baseline (Week 0) and Post-Intervention (Week 12)
Measured using the AGIO Human Resource Productivity Scale (Hersey and Blanchard, 1980) with 7 subscales: ability, role clarity, organizational support, motivation, feedback, credibility, and environmental adaptability. Scores range from 1 to 5, with higher scores indicating greater productivity.
Baseline (Week 0) and Post-Intervention (Week 12)
360-Degree Performance Evaluation Score
時間枠:Baseline (Week 0) and Post-Intervention (Week 12)
Description: Measured using the 360-Degree Performance Evaluation Questionnaire (Poursoltani et al., 2010) with 4 sources: supervisor, peer, subordinate, and self. Scores range from 1 to 5, with higher scores indicating better performance.
Baseline (Week 0) and Post-Intervention (Week 12)
Herzberg Job Motivation Score
時間枠:Baseline (Week 0) and Post-Intervention (Week 12)
Measured using the Herzberg Dual-Factor Motivation Questionnaire (Darchini, 2015) assessing intrinsic (motivational) and extrinsic (hygiene) factors. Scores range from 1 to 5, with higher scores indicating greater job motivation.
Baseline (Week 0) and Post-Intervention (Week 12)
Walton Quality of Work Life Score
時間枠:Baseline (Week 0) and Post-Intervention (Week 12)
Measured using the Walton Quality of Work Life Questionnaire (Walton, 1973; Iranian validation by Rahimi, 2005) with 8 dimensions including fair compensation, safe working conditions, and growth opportunities. Scores range from 1 to 5, with higher scores indicating better quality of work life.
Baseline (Week 0) and Post-Intervention (Week 12)

二次結果の測定

結果測定
メジャーの説明
時間枠
AGIO Subscale Scores
時間枠:Baseline (Week 0) and Post-Intervention (Week 12)
Individual subscale scores of the AGIO Human Resource Productivity Scale (Hersey and Blanchard, 1980) including Ability, Role Clarity, Organizational Support, Motivation, Feedback, Credibility, and Environmental Fit. Each subscale score ranges from 1 to 5, with higher scores indicating greater productivity.
Baseline (Week 0) and Post-Intervention (Week 12)
Herzberg Factor Scores
時間枠:Baseline (Week 0) and Post-Intervention (Week 12)
Separate scores for the Intrinsic/Motivator factors and Extrinsic/Hygiene factors of the Herzberg Dual-Factor Motivation Questionnaire (Darchini, 2015). Each factor score ranges from 1 to 5, with higher scores indicating greater job motivation.
Baseline (Week 0) and Post-Intervention (Week 12)

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2002年4月21日

一次修了 (実際)

2025年7月15日

研究の完了 (実際)

2025年7月15日

試験登録日

最初に提出

2026年9月7日

QC基準を満たした最初の提出物

2026年9月11日

最初の投稿 (実際)

2026年9月17日

学習記録の更新

投稿された最後の更新 (実際)

2026年9月17日

QC基準を満たした最後の更新が送信されました

2026年9月11日

最終確認日

2026年9月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

未定

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する